Citius Oncology (CTOR) Price to Book (2022 - 2026)

Citius Oncology (CTOR) has reported Price to Book for 5 consecutive years, with 1.7 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Book fell 82.28% year-over-year to 1.7 in Q2 2026; TTM through Jun 2026 was 1.7, a 82.28% decrease from a year earlier, with the FY2025 full-year figure at 3.78, up 75.3% from the prior year.
• Price to Book was 1.7 for Q2 2026 at Citius Oncology, up from 1.63 in the prior quarter.
• Over five years, Price to Book peaked at 472.28 in Q1 2023 and troughed at 48241.1 in Q2 2023.
• A 5-year average of 3173.8 and a median of 2.64 in 2024 frame the typical range for Price to Book.
• Across the five-year window, Price to Book sank 99.44% in 2024 and surged 116.49% in 2025, its largest moves.
• Over 5 years, Price to Book stood at 94.31 in 2022, then plunged by 65.55% to 32.49 in 2023, then tumbled by 93.87% to 1.99 in 2024, then dropped by 27.16% to 1.45 in 2025, then grew by 17.26% to 1.7 in 2026.
• The last three Price to Book figures came in at 1.7 (Q2 2026), 1.63 (Q1 2026), and 1.45 (Q4 2025), per Business Quant data.